Grid-enabled high throughput in-silico screening against influenza A neuraminidase

PCSV, présenté par H.-C. Lee, à paraître dans les proceedings Encouraged by the success of first EGEE biomedical data challenge against malaria[1], the second data challenge was kicked off in April, 2006, fighting against avian flu. In the paper, we demonstrated how to adopt a world-wide deployed Gr...

Full description

Bibliographic Details
Main Authors: Lee, H.-C., Salzemann, J., Jacq, N., Ho, L.-Y., Chen, H.-Y., Breton, Vincent, Merelli, I., Milanesi, L., C. Lin, S., Wu, Y.-T.
Other Authors: Laboratoire de Physique Corpusculaire - Clermont-Ferrand (LPC), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Centre National de la Recherche Scientifique (CNRS)
Format: Conference Object
Language:English
Published: HAL CCSD 2006
Subjects:
Online Access:https://hal.in2p3.fr/in2p3-00114348
https://hal.in2p3.fr/in2p3-00114348/document
https://hal.in2p3.fr/in2p3-00114348/file/Nettab2.pdf
Description
Summary:PCSV, présenté par H.-C. Lee, à paraître dans les proceedings Encouraged by the success of first EGEE biomedical data challenge against malaria[1], the second data challenge was kicked off in April, 2006, fighting against avian flu. In the paper, we demonstrated how to adopt a world-wide deployed Grid infrastructure to efficiently produce a large scale virtual screening to speed up the drug design process. The 6-weeks activity of molecular docking on the Grid has covered over 100 years of computing power required for discovering new drug for avian flu. Around 600 Gigabytes of output has also been produced and archived on the Grid for further biological analysis and test.